abrdn Healthcare Investors - SH BEN INT (HQH)

Historical Holders from Q3 2014 to Q3 2025

Symbol
HQH on NYSE
Type / Class
Equity / SH BEN INT
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
12,057,265
Holdings value
$222,373,596
% of all portfolios
0%
Number of holders
118
Number of buys
65
Number of sells
-44
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of abrdn Healthcare Investors - SH BEN INT (HQH)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 12,057,265 $222,373,596 +$8,839,055 $18.46 118
2025 Q2 11,631,117 $180,161,828 -$2,963,522 $15.49 112
2025 Q1 11,775,378 $191,293,311 -$5,891,757 $16.24 103
2024 Q4 12,232,485 $196,507,107 -$15,523,460 $16.05 115
2024 Q3 12,972,660 $241,465,207 +$5,769,648 $18.62 117
2024 Q2 12,713,002 $221,901,073 -$2,421,761 $17.46 110
2024 Q1 12,848,172 $216,469,442 +$5,737,211 $16.86 117
2023 Q4 12,518,972 $207,722,755 +$33,930,287 $16.57 121
2023 Q3 10,293,378 $160,060,634 +$15,226,457 $15.55 113
2023 Q2 9,300,163 $158,567,667 +$10,564,865 $17.05 115
2023 Q1 8,645,641 $152,559,419 +$1,091,744 $17.65 115
2022 Q4 8,555,451 $154,111,766 +$4,966,821 $18 111
2022 Q3 8,207,383 $141,846,783 +$4,282,136 $17.28 96
2022 Q2 7,967,362 $148,986,369 -$1,950,171 $18.69 96
2022 Q1 8,083,014 $167,898,864 -$5,161,243 $20.77 94
2021 Q4 8,241,249 $195,765,803 -$9,245,226 $23.76 99
2021 Q3 8,613,095 $220,235,973 -$7,498,630 $25.57 95
2021 Q2 8,909,654 $229,250,718 -$19,531,264 $25.73 106
2021 Q1 9,662,227 $235,767,469 -$11,602,770 $24.41 107
2020 Q4 10,158,866 $241,951,588 +$1,625,395 $23.83 107
2020 Q3 9,962,767 $205,459,927 +$3,584,233 $20.62 91
2020 Q2 10,091,306 $215,150,820 +$1,124,321 $21.33 98
2020 Q1 9,611,163 $171,294,952 -$3,338,886 $17.81 100
2019 Q4 9,792,272 $204,475,298 +$5,059,277 $20.88 92
2019 Q3 8,955,896 $164,383,014 -$5,175,234 $18.34 88
2019 Q2 9,226,308 $185,184,098 +$5,740,686 $20.08 84
2019 Q1 9,058,608 $185,936,302 +$5,997,664 $20.54 85
2018 Q4 8,805,478 $158,057,336 -$2,026,613 $17.95 90
2018 Q3 8,748,202 $202,487,186 +$6,320,572 $23.15 86
2018 Q2 8,487,857 $182,510,912 +$5,249,595 $21.5 84
2018 Q1 8,245,064 $177,576,894 +$3,763,984 $21.53 84
2017 Q4 8,036,663 $181,231,522 +$21,267,986 $22.55 90
2017 Q3 6,964,617 $175,707,135 +$4,717,754 $25.23 66
2017 Q2 6,776,617 $170,093,048 +$983,920 $25.1 59
2017 Q1 6,736,758 $161,880,973 -$3,512,985 $24.04 62
2016 Q4 6,914,408 $146,318,733 +$4,892,282 $21.13 65
2016 Q3 6,667,120 $158,560,954 +$4,105,892 $23.81 65
2016 Q2 6,558,256 $153,909,923 -$17,264,555 $23.44 64
2016 Q1 7,262,387 $174,261,136 -$6,582,109 $24 64
2015 Q4 7,487,778 $221,968,299 +$21,775,932 $29.66 67
2015 Q3 6,789,079 $187,720,080 -$3,890,816 $27.6 62
2015 Q2 6,879,216 $244,582,907 +$5,542,575 $35.54 59
2015 Q1 6,714,146 $233,943,550 +$582,886 $34.85 57
2014 Q4 6,703,305 $211,144,435 +$200,806,995 $31.49 58
2014 Q3 72,080 $2,047,000 +$2,047,000 $28.39 6